Introduction to Videx EC
Videx EC is the brand name for an enteric-coated formulation of didanosine, USP, active against HIV-1.
Description
Videx EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Videx EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administration in strengths of 125, 200, 250, and 400 mg of didanosine.
Dosage Recommendations
Recommended dosage of Videx EC ranges from 200 to 400 mg daily, to be taken once a day.
Timing of Administration
Videx EC should be administered on an empty stomach, either at least 30 minutes before or 2 hours after eating. This medication is available in several strengths and should be swallowed intact. For detailed dosing recommendations, consult the prescribing information for Videx EC.
Special Populations
Special populations, such as individuals with impaired kidney function, may require dosage adjustments when prescribed Videx EC. It is essential to consult healthcare providers for personalized dosing recommendations in specific populations.
Dosage Modifications and Considerations
Healthcare providers may adjust Videx EC dosage based on kidney function and specific patient needs.
Kidney Function
If kidney function is impaired, healthcare providers may consider adjusting the dosage of Videx EC accordingly. Consult with your healthcare provider for personalized recommendations based on your kidney function.
Drug Interactions
When coadministered with other drugs, Videx EC may have diverse effects on pharmacokinetics. It is crucial to review drug interaction studies and consult healthcare providers for guidance on managing potential interactions.
Pediatric Dosage and Administration
Videx EC is used to treat HIV infection in children and adults. Consult healthcare providers before administration.
Oral Solutions
When administering Videx EC as an oral solution, follow detailed dosage guidelines and administration instructions to ensure proper intake and effectiveness. Consult healthcare providers for specific recommendations.
Specific Considerations
When prescribing Videx EC, specific considerations should be taken into account, especially regarding dosing adjustments, potential drug interactions, and individual patient factors. Healthcare providers play a crucial role in ensuring safe and effective administration based on these considerations.
Safety and Monitoring
Common side effects of Videx EC include nausea, diarrhea, and headache. Monitoring parameters include renal function and liver enzymes.
Side Effects
Common side effects of Videx EC include nausea, diarrhea, and headache. It is essential to monitor renal function and liver enzymes as part of the safety measures.
Monitoring Parameters
Monitoring parameters for patients taking Videx EC should include renal function tests and liver enzyme levels to assess the medication’s safety and efficacy. Regular monitoring of these parameters is essential to ensure proper management of HIV-1 infection while minimizing potential adverse effects.